EPRX CIK: 1581178

Eupraxia Pharmaceuticals Inc.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
18.6
FY23:
19.8
FY24:
34.4
FY25:
85.1
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.53
FY23:
0.46
FY24:
0.51
FY25:
1.05
Total assets
Change from FY22 to FY25
millions USD
FY22:
19.1
FY23:
20.3
FY24:
34.9
FY25:
86.2

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
3.06
FY23:
19.4
FY24:
3.10
FY25:
5.63
(negative)
Change from FY22 to FY25
millions USD
FY22:
8.86
FY23:
0
FY24:
0
FY25:
0.08
(positive)
Change from FY22 to FY25
millions USD
FY22:
7.79
FY23:
2.22
FY24:
33.4
FY25:
82.0
Total liabilities & equity
millions USD
FY22:
19.7
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR